XUCS:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI USA Consumer Staples UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 40.34

Change

+0.51 (+1.28)%

Market Cap

USD 0.09B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.01 (-0.02%)

USD 116.66B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.06 (-0.11%)

USD 91.05B
SXR8:F iShares Core S&P 500 UCITS ETF..

-2.32 (-0.45%)

USD 85.22B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.04 (-0.19%)

USD 74.74B
EUNL:F iShares Core MSCI World UCITS ..

-0.55 (-0.59%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.20%)

USD 55.89B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.03 (-0.20%)

USD 55.84B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.29 (-0.31%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.31 (-0.33%)

USD 51.63B

ETFs Containing XUCS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.98% 73% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.98% 70% C- 62% D
Trailing 12 Months  
Capital Gain 4.09% 42% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.09% 40% F 49% F
Trailing 5 Years  
Capital Gain 45.42% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.42% 64% D 54% F
Average Annual (5 Year Horizon)  
Capital Gain 6.48% 70% C- 68% D+
Dividend Return 6.48% 69% C- 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.57% 58% F 80% B-
Risk Adjusted Return 61.32% 87% B+ 88% B+
Market Capitalization 0.09B 25% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.